NKA Bio was founded with a mission to improve trauma care by solving shock. The company is focused on its primary product NKA01 for Trauma Resuscitation. The early-stage pipeline in development includes programs for septic shock, acute lung injury, and heart attack resuscitation.
Location: United States, Maryland, Baltimore
Employees: 1-10
Total raised: $30K
Founded date: 2023
Investors 1
| Date | Name | Website |
| 27.10.2023 | The Innova... | innovation... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.04.2023 | Seed | $30K | - |